硕世生物跌2.08%，成交额5897.92万元，主力资金净流出268.77万元

Company Overview - Jiangsu Shuoshi Biological Technology Co., Ltd. was established on April 12, 2010, and listed on December 5, 2019. The company specializes in the research, production, and sales of in vitro diagnostic reagents and related testing instruments [2] - The main business revenue composition includes: testing reagents 85.89%, purchased instruments and materials 7.19%, testing instruments 3.84%, testing services 2.24%, and others 0.84% [2] - As of September 19, the number of shareholders is 8,000, a decrease of 4.82% from the previous period, with an average of 10,483 circulating shares per person, an increase of 5.06% [2] Financial Performance - For the first half of 2025, the company achieved operating revenue of 176 million yuan, a year-on-year decrease of 1.05%, and a net profit attributable to the parent company of 3.99 million yuan, a year-on-year decrease of 86.35% [2] - The company has distributed a total of 1.37 billion yuan in dividends since its A-share listing, with 285 million yuan distributed over the past three years [3] Stock Performance - As of September 26, the stock price of Shuoshi Biological fell by 2.08% to 64.02 yuan per share, with a total market value of 5.369 billion yuan [1] - Year-to-date, the stock price has increased by 56.13%, but it has decreased by 5.28% in the last five trading days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with a net purchase of 19.7845 million yuan on February 17 [1] Institutional Holdings - As of June 30, 2025, the third-largest circulating shareholder is Huaxia Industry Prosperity Mixed A (003567), holding 2.2546 million shares, an increase of 1.0079 million shares from the previous period [3]